CCM
TMO icon

Cribstone Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Cribstone Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$47.9K Hold
87
– – 0.03% 165
2022
Q3 		$44K Sell
87
-10
-10% -$5.6K 0.03% 163
2022
Q2 		$53K Buy
97
+1
+1% +$550 0.03% 157
2022
Q1 		$57K Sell
96
-14
-13% -$8.04K 0.03% 156
2021
Q4 		$73K Hold
110
– – 0.04% 149
2021
Q3 		$63K Sell
110
-10
-8% -$5.49K 0.04% 154
2021
Q2 		$61K Hold
120
– – 0.04% 149
2021
Q1 		$55K Hold
120
– – 0.04% 150
2020
Q4 		$56K Hold
120
– – 0.04% 151
2020
Q3 		$53K Hold
120
– – 0.04% 125
2020
Q2 		$43K Hold
120
– – 0.04% 133
2020
Q1 		$34K Sell
120
-6
-5% -$1.89K 0.04% 131
2019
Q4 		$41K Sell
126
-200
-61% -$60.6K 0.04% 153
2019
Q3 		$95K Sell
326
-148
-31% -$42.4K 0.06% 161
2019
Q2 		$139K Sell
474
-37
-7% -$10.2K 0.08% 136
2019
Q1 		$140K Sell
511
-30
-6% -$7.47K 0.07% 134
2018
Q4 		$121K Sell
541
-205
-27% -$48.1K 0.06% 151
2018
Q3 		$182K Sell
746
-20
-3% -$4.6K 0.08% 128
2018
Q2 		$159K Buy
766
+45
+6% +$9.55K 0.08% 133
2018
Q1 		$149K Buy
721
+83
+13% +$17.4K 0.07% 140
2017
Q4 		$121K Buy
638
+13
+2% +$2.49K 0.06% 189
2017
Q3 		$118K Hold
625
– – 0.06% 161
2017
Q2 		$109K Buy
625
+50
+9% +$8.4K 0.06% 171
2017
Q1 		$88K Hold
575
– – 0.05% 211
2016
Q4 		$83K Hold
575
– – 0.05% 197
2016
Q3 		$87K Hold
575
– – 0.05% 185
2016
Q2 		$85K Buy
+575
New +$84.9K 0.05% 197

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cribstone Capital Management's TMO Position: Q4 2022 in Review

Cribstone Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q4 2022 at 87 shares worth $47.9K. The position accounts for 0.03% of the portfolio, ranked #165.

Cribstone Capital Management first reported a position in TMO in Q2 2016 and has held it in 27 quarters since. The position peaked at $182K in Q3 2018. 2,374 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

  • Cribstone Capital Management held 87 shares of Thermo Fisher Scientific worth $47.9K as of Q4 2022.
  • Cribstone Capital Management left its Thermo Fisher Scientific share count unchanged in Q4 2022.
  • Thermo Fisher Scientific made up 0.03% of Cribstone Capital Management's portfolio in Q4 2022, its #165 holding.
  • Cribstone Capital Management first reported a position in Thermo Fisher Scientific in Q2 2016 and has held it in 27 quarters since.
  • Cribstone Capital Management's Thermo Fisher Scientific position peaked at $182K in Q3 2018.
  • 2,374 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.